Hypoalphalipoproteinemia, Primary, 2 (FHA2)

Alias:

Apolipoprotein a-I Deficiency

Hypoalphalipoproteinemia, Primary, 2, Autosomal Recessive

High Density Lipoprotein Deficiency

Primary Hypoalphalipoproteinemia 2

Familial Hypoalphalipoproteinemia

Familial Apoa-I Deficiency

Apoa-I Deficiency

Apoa-I and Apoc-Iii Deficiency, Combined

Apolipoprotein a-I

Fha2

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Hypoalphalipoproteinemia, Primary, 2, also known as apolipoprotein a-i deficiency, is related to hypoalphalipoproteinemia, primary, 2, intermediate and tangier disease. An important gene associated with Hypoalphalipoproteinemia, Primary, 2 is APOA1 (Apolipoprotein A1), and among its related pathways/superpathways are Metabolism and Transport of inorganic cations/anions and amino acids/oligopeptides. The drugs Acetylsalicylic acid and Atorvastatin have been mentioned in the context of this disorder. Affiliated tissues include heart and endothelial, and related phenotypes are opacification of the corneal stroma and abnormal circulating lipid concentration

Related ID：

MALACARDS：HYP843

OMIM：618463

MESH：D052456